|
|
Neuer Ziel fuer die Arzneimittelentwicklung gegen "triple-negative" Brustkrebs identifiziert10/8/2013 Neuer Ziel fuer die Arzneimittelentwicklung gegen "triple-negative" Brustkrebs identifiziert ("triple-negative" Brustkrebs: Einer der meist aggressiven, therapie-resistenten und metastatischen Tumoren!)
#Brustkrebs #cancersimplified http://preview.medicalnewstoday.com/releases/267000
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
Archives
September 2019
Categories
All
|
|
Copyright © 2013-2019 Cancer Education and Research Institute® (fka CancerResearchSimplified). All Rights Reserved.
Powered by Cancer Education and Research Institute® |
|
|
RSS Feed
